story of the week
Anti-TNF Treatment for the Prevention of Ischemic Events in Patients With DADA2
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Disclosure statements are available on the authors' profiles:
Rheumatology (Oxford, England)
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
Anti-tumour necrosis factor treatment for the prevention of ischaemic events in patients with deficiency of adenosine deaminase 2 (DADA2)
Rheumatology (Oxford) 2021 Sep 01;60(9)4373-4378, S Cooray, E Omyinmi, Y Hong, C Papadopoulou, L Harper, E Al-Abadi, R Goel, S Dubey, M Wood, S Jolles, S Berg, M Ekelund, K Armon, D Eleftheriou, PA BroganFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.